Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: July 2005

VistaGen Therapeutics (VSTA) Awarded $197,000 NIH Grant for Expanded PreclinicalDevelopment of New Drug Candidate for Neuropathic Pain

VistaGen Therapeutics, Inc., a development stage biopharmaceutical company focused on discovering, developing and commercializing novel small molecule and protein therapeutics for Central Nervous System (CNS) and Peripheral Nervous System (PNS) disorders and metabolic diseases using embryonic stem cell technologies, announced … Continue reading

Posted in VistaGen Therapeutics Inc. VSTA | Leave a comment